OIE Reference Laboratory Reports Activities

Transcription

1 OIE Reference Laboratory Reports Activities Activities in 2017 This report has been submitted : :42:59 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Foot and mouth disease Address of laboratory: Av. President Kennedy Duque de Caxias Rio de Janeiro BRAZIL Tel.: Fax: address: arivera@paho.org Website: Name (including Title) of Head of Laboratory (Responsible Official): Ottorino Cosivi, Medico Veterinario Director Centro Panamericano de Fiebre Aftosa - PANAFTOSA/PAHO/WHO Name (including Title and Position) of OIE Reference Expert: Rossana Allende Head Reference Laboratory Which of the following defines your laboratory? Check all that apply: Other: United Nations Agency OIE Reference Laboratory Reports Activities,

2 ToR 1: To use, promote and disseminate diagnostic methods validated according to OIE Standards 1. Did your laboratory perform diagnostic tests for the specified disease/topic for purposes such as disease diagnosis, screening of animals for export, surveillance, etc.? (t for quality control, proficiency testing or staff training) Diagnostic Test Indicated in OIE Manual (/) Total number of test performed last year Indirect diagnostic tests Nationally Internationally I-ELISA 3ABC/EITB yes Lph-ELISA yes 0 21 Virus neutralization yes 0 82 Direct diagnostic tests Nationally Internationally Viral isolation yes 0 2 Ag ELISA yes 0 4 RT-PCR gen 3D yes 0 4 RT-PCR typing yes 0 4 ToR 2: To develop reference material in accordance with OIE requirements, and implement and promote the application of OIE Standards. To store and distribute to national laboratories biological reference products and any other reagents used in the diagnosis and control of the designated pathogens or disease. 2. Did your laboratory produce or supply imported standard reference reagents officially recognised by the OIE? NOTE: Currently, there are 22 laboratories that produce Standard Reference Reagents officially recognised by the OIE for 19 diseases/pathogens. Please click the following link to the list of OIE-approved International Standard Sera: If the reagent is not listed on this page, it is NOT considered OIE-approved. The next two questions allow you to indicate non-oie-approved diagnostic reagents. 2 OIE Reference Laboratory Reports Activities, 2017

3 Disease Test Available from Foot and mouth disease nstructural protein tests Dr Rossana Allende Centro Panamericano de Fiebre Aftosa OPS/OMS, Av. President Kennedy 7778, Sao Bento, Duque de Caxias, ZC Rio de Janeiro, Brazil Tel: (55-21) Fax: (55-21) Type of reagent available Related diagnostic test Produced/ Supply imported Amount supplied nationally (ml, mg) Amount supplied internationally (ml, mg) Name of recipient OIE Member Countries NCPanaftosa System ELISA 3ABC/EITB NSP antibodies test produced <10mL mL mL >500mL <10mL mL mL >500mL ARGENTINA BOLIVIA BRAZIL COLOMBIA KENYA KOREA (REP. OF) PARAGUAY PERU URUGUAY VENEZUELA 3. Did your laboratory supply standard reference reagents (non OIE-approved) and/or other diagnostic reagents to OIE Member Countries? OIE Reference Laboratory Reports Activities,

4 Type of reagent available Related diagnostic test Produced/ provide Amount supplied nationally (ml, mg) Amount supplied internationally (ml, mg). of recipient OIE Member Countries Region of recipients Ag Typing ELISA FMDV/VSV Antigen Typing produced non applicable 3, tests aprox 7 Africa America s Asia and Pacific Europe Middle East Lph-CELISA FMD SP antibodies detection produced non applicable 600, test aprox 5 Africa America s Asia and Pacific Europe Middle East PCR FMDV positive control PCR tests produced non applicable 12 ml 1 Africa America s Asia and Pacific Europe Middle East Cell seeds Viral isolation/vaccine production produced non applicable 100 ml 2 Africa America s Asia and Pacific Europe Middle East 4. Did your laboratory produce vaccines? 5. Did your laboratory supply vaccines to OIE Member Countries? ToR 3: To develop, standardise and validate, according to OIE Standards, new 4 OIE Reference Laboratory Reports Activities, 2017

5 procedures for diagnosis and control of the designated pathogens or diseases 6. Did your laboratory develop new diagnostic methods validated according to OIE Standards for the designated pathogen or disease? 7. Did your laboratory develop new vaccines according to OIE Standards for the designated pathogen or disease? ToR 4: To provide diagnostic testing facilities, and, where appropriate, scientific and technical advice on disease control measures to OIE Member Countries 8. Did your laboratory carry out diagnostic testing for other OIE Member Countries? Name of OIE Member Country seeking assistance Date (month). samples received for provision of diagnostic support. samples received for provision of confirmatory diagnoses COLOMBIA July/ SURINAME April/ URUGUAY August/ PERU October/ Did your laboratory provide expert advice in technical consultancies on the request of an OIE Member Country? Name of the OIE Member Country receiving a technical consultancy Purpose How the advice was provided COLOMBIA FMD diagnosis and vaccine quality control Technical advice in situ PARAGUAY FMD vaccine quality control Technical advice in situ SURINAME FMD Serosurveillance Technical advice in situ and training in PANAFTOSA Reference lab URUGUAY Interpretation of NSP test results Technical advice at distance OIE Reference Laboratory Reports Activities,

6 ToR 5: To carry out and/or coordinate scientific and technical studies in collaboration with other laboratories, centres or organisations 10. Did your laboratory participate in international scientific studies in collaboration with OIE Member Countries other than the own? Title of the study Duration Purpose of the study Partners (Institutions) OIE Member Countries involved other than your country FMD serosurveillance 1 month Verify absence FMD virus circulation in the country Department Animal Production and Health Veterinary Services SURINAME ToR 6: To collect, process, analyse, publish and disseminate epizootiological data relevant to the designated pathogens or diseases 11. Did your Laboratory collect epizootiological data relevant to international disease control? 12. Did your laboratory disseminate epizootiological data that had been processed and analysed? 13. What method of dissemination of information is most often used by your laboratory? (Indicate in the appropriate box the number by category) a) Articles published in peer-reviewed journals: 1 Clavijo A, Sanchez-Vazquez MJ, Buzanovsky LP, Martini M, Pompei JC, Cosivi O. Current Status and Future Prospects to Achieve Foot-and-Mouth Disease Eradication in South America. Transbound Emerg Dis Feb; 64(1): doi: /tbed Review. b) International conferences: 10 INFORME DE LA SECRETARIA Ex Officio a la 44 Reunión de la Comisión Sudamericana para la lucha contra la Fiebre Aftosa COSALFA Alejandro Rivera - PANAFTOSA - OPS/OMS) LABORATORIO DE PRODUCCIÓN DE PANAFTOSA - Júlio César Augusto Pompei - PANAFTOSA - OPAS/OMS) INFORME DE LA SECRETARIA EX OFFICIO A LA 44ª. REUNIÓN DE LA COMISIÓN SUDAMERICANA DE LUCHA CONTRA LA FIEBRE AFTOSA (COSALFA 44) COOPERACIÓN TÉCNICA DE PANAFTOSA-LABORATORIO DE REFERENCIA FIEBRE AFTOSA/ESTOMATITIS VESICULAR Rossana M. Allende -PANAFTOSA - OPS/OMS 6 OIE Reference Laboratory Reports Activities, 2017

7 Informe de situación sanitaria de los países Manuel J Sanchez Vazquez PANAFTOSA- OPS/OMS INFORME SEMINARIO INTERNACIONAL Pre-COSALFA. Alejandro Rivera - PANAFTOSA - OPS/OMS RIESGO ACTUAL DE VIRUS C EN LA REGION SUDAMERICANA. Alejandro M. Rivera -PANAFTOSA OPS/OMS BANCO DE VACUNAS Y ANTÍGENOS DE COSALFA BANVACO. Ottorino Cosivi- PANAFTOSA - OPS/OMS Recomendaciones para el manejo de cepas de virus de FA exógenas a la región. Rossana Allende, PANAFTOSA- OPS/OMS. PROGRAMA DE APOYO PARA LA CAPACITACIÓN DE LOS SVO DE LOS PAÍSES DEL CONO SUR PARA ENFRENTAR LA ÚLTIMA ETAPA DEL PHEFA. Comité Veterinario Permanente del Cono Sur Presidencia pro tempore en Bolivia - Dr. Javier Suárez Hurtado Presidente pro tempore CVP c) National conferences: 0 d) Other: (Provide website address or link to appropriate information) 6 R. Allende - II Taller internacional de diagnóstico diferencial de fiebre aftosa - Informe Final Centro Panamericano de Fiebre Aftosa. Guía Técnica de Trabajo para la Ultima Etapa del Programa Hemisférico de Erradicación de Fiebre Aftosa - PHEFA - 2.ed. Río de Janeiro: PANAFTOSA - OPS/OMS, p. Centro Panamericano de Fiebre Aftosa. Informe de Situación de los Programas de Erradicación de la Fiebre Aftosa. Sudamérica y Panamá, año Rio de Janeiro: PANAFTOSA-OPS/OMS, p. INFORME TÉCNICO FOCO DE FIEBRE AFTOSA MUNICIPIO DE TAME - COLOMBIA NOTA TÉCNICA EVALUACION DE RIESGO DE VIRUS C DE FIEBRE AFTOSA EVALUACIÓN DE RIESGO DE VIRUS DE FIEBRE AFTOSA TIPO C EN SUDAMÉRICA En seguimiento de la Resolución III de la Reunión COSALFA 43 ToR 7: To provide scientific and technical training for personnel from OIE Member Countries To recommend the prescribed and alternative tests or vaccines as OIE Standards 14. Did your laboratory provide scientific and technical training to laboratory personnel from other OIE Member Countries? OIE Reference Laboratory Reports Activities,

8 a) Technical visits: 2 b) Seminars: 1 c) Hands-on training courses: 1 d) Internships (>1 month): 0 Type of technical training provided (a, b, c or d) Country of origin of the expert(s) provided with training. participants from the corresponding country Technical visits Colombia 6 Technical visits Paraguay 8 Seminars All South American countries and Panamá 32 Hands-on training courses Suriname 1 ToR 8: To maintain a system of quality assurance, biosafety and biosecurity relevant for the pathogen and the disease concerned 15. Does your laboratory have a Quality Management System certified according to an International Standard? Quality management system adopted ISO 17025:2005 Certificate scan (PDF, JPG, PNG format) CRL 1309 PANAFTOSA Certificate.pdf 16. Is your laboratory accredited by an international accreditation body? Test for which your laboratory is accredited I-ELISA 3ABC EITB Accreditation body INMETRO - Brazil INMETRO - Brazil 17. Does your laboratory maintain a biorisk management system for the pathogen and the disease concerned? (See Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 1.1.4) 8 OIE Reference Laboratory Reports Activities, 2017

9 ToR 9: To organise and participate in scientific meetings on behalf of the OIE 18. Did your laboratory organise scientific meetings on behalf of the OIE? 19. Did your laboratory participate in scientific meetings on behalf of the OIE? ToR 10: To establish and maintain a network with other OIE Reference Laboratories designated for the same pathogen or disease and organise regular inter-laboratory proficiency testing to ensure comparability of results 20. Did your laboratory exchange information with other OIE Reference Laboratories designated for the same pathogen or disease? 21. Was your laboratory involved in maintaining a network with OIE Reference Laboratories designated for the same pathogen or disease by organising or participating in proficiency tests? Purpose of the proficiency tests: 1 Role of your Reference Laboratory (organiser/ participant). participants Participating OIE Ref. Labs/ organising OIE Ref. Lab. Determining capability of laboratories to conduct FMD antigen detection tests participant unknown Organized by The Pibright/UK Institute Determining laboratory's capability to conduct FMD antibody detection tests participant unknown Organized by The Pibright/UK Institute Determining capability of laboratories to conduct FMD molecular detection tests organizer 12 laboratories FMD OIE and FAO Reference labs from Argentina, USA and Canadá were among participants labs. 1 validation of a diagnostic protocol: specify the test; quality control of vaccines: specify the vaccine type, etc. 22. Did your laboratory collaborate with other OIE Reference Laboratories for the same disease on scientific research projects for the diagnosis or control of the pathogen of interest? OIE Reference Laboratory Reports Activities,

10 ToR 11: To organise inter-laboratory proficiency testing with laboratories other than OIE Reference Laboratories for the same pathogens and diseases to ensure equivalence of results 23. Did your laboratory organise or participate in inter-laboratory proficiency tests with laboratories other than OIE Reference Laboratories for the same disease? te: See Interlaboratory test comparisons in: Laboratory Proficiency Testing at: see point 1.3 Purpose for inter-laboratory test comparisons 1. participating laboratories Region(s) of participating OIE Member Countries Determining laboratory's capability to condut FMD/VSV nucleic acid detection test 12 Africa Americas Asia and Pacific Europe Middle East ToR 12: To place expert consultants at the disposal of the OIE 24. Did your laboratory place expert consultants at the disposal of the OIE? Kind of consultancy Location Subject (facultative) FMD Ad hoc group Paris, France FMD status of countries Mission to country Venezuela Revision of FMD eradication program Provision of comments on OIE Standards Brazil Revision of FMD Chapter of OIE Terrestrial Manual Provision of comments on OIE Standards Brazil Revision of OIE Guidelines for Reference Material preparation 25. Additional comments regarding your report: 10 OIE Reference Laboratory Reports Activities, 2017